Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34
Discovering New Therapeutic Targets for Alzheimer’s Disease
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, with a high risk of failure. Strategic...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours
Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms
Despite the urgent danger of antibiotic resistance, investments into European biotech antibiotic players have remained flat. However, growing regulatory and societal awareness could spell fresh...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 jours
What Makes a Good Chief Financial Officer in the Biotech Industry?
A chief financial officer in the life sciences needs to develop their skills beyond technical expertise. Catherine Moukheibir shares her advice for CFOs in biotech drawing from her experience being...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine
Blood Cells: The Future of Drug Delivery
From red blood cells to platelets, the cells in our own blood could prove an effective way of delivering drugs to their target and improving their safety. Many pharmaceutical drugs in the market come...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine
UK Startup Surfs Investment Wave in Microbiome with €18M Series A
As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series A fundraising to potentially treat a myriad of medical conditions by improving gut...
www.labiotech.eu
Charger plus d'actualités

Informations juridiques
SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne